Bausch Health Companies (BHC) Exchange Rate Effect (2009 - 2026)
Bausch Health Companies (BHC) reported Exchange Rate Effect of -$4.0 million for Q1 2026, down 119.05% on a YoY basis from $21.0 million in Q1 2025, and down 157.14% sequentially from $7.0 million in Q4 2025.
Bausch Health Companies (BHC) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Exchange Rate Effect data on file, last reported at -$4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 119.05% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at $36.0 million (up 460.0% YoY), and the FY2025 full-year result was $61.0 million, up 269.44% from the prior year.
- Exchange Rate Effect declined to -$4.0 million in Q1 2026, from $7.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $39.0 million in Q2 2025 to a low of -$35.0 million in Q4 2024.
- A 5-year average of $411764.7 and a median of -$4.0 million in 2026 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect surged 875.0% in 2022 and plunged 1000.0% in 2024, its largest moves.
- Tracing BHC's Exchange Rate Effect over 5 years: stood at $31.0 million in 2022, then sank by 38.71% to $19.0 million in 2023, then tumbled by 284.21% to -$35.0 million in 2024, then jumped by 120.0% to $7.0 million in 2025, then tumbled by 157.14% to -$4.0 million in 2026.
- Business Quant data shows BHC's Exchange Rate Effect at -$4.0 million in Q1 2026, $7.0 million in Q4 2025, and -$6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Dec 31, 2024 | -35.00 Mn |
| Dec 31, 2024 | -35.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | 19.00 Mn |
| Dec 31, 2023 | 19.00 Mn |